Our data showed that the expression level of MCU in BC cell lines with higher invasive potential, such as MDA-MB-231, BT-549, and SUM-159-PT, was significantly higher than that in MCF-7, T-47D and BT-474 cells (P<0.01; Figure 2C, D). This evidence concerns the gene MCU and breast cancer.